NO20005548D0 - Mykobakterieinhibitorer - Google Patents

Mykobakterieinhibitorer

Info

Publication number
NO20005548D0
NO20005548D0 NO20005548A NO20005548A NO20005548D0 NO 20005548 D0 NO20005548 D0 NO 20005548D0 NO 20005548 A NO20005548 A NO 20005548A NO 20005548 A NO20005548 A NO 20005548A NO 20005548 D0 NO20005548 D0 NO 20005548D0
Authority
NO
Norway
Prior art keywords
mykobakterieinhibitorer
treatment
certain
provides
mycobacterial diseases
Prior art date
Application number
NO20005548A
Other languages
English (en)
Other versions
NO20005548L (no
Inventor
Meenakshi Balganesh
Kantharaj Ethiraj
Babita Ganguly
Ramachandran Janakiraman
Parvinder Kaur
Rangarao Kajipala
Santosh Nandan
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9802118A external-priority patent/SE9802118D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20005548D0 publication Critical patent/NO20005548D0/no
Publication of NO20005548L publication Critical patent/NO20005548L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035Isoindoles, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/45Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20005548A 1998-05-05 2000-11-03 Mykobakterieinhibitorer NO20005548L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN969MA1998 1998-05-05
SE9802118A SE9802118D0 (sv) 1998-06-15 1998-06-15 Mycobacterial inhibitors
PCT/SE1999/000732 WO1999065483A1 (en) 1998-05-05 1999-05-03 Mycobacterial inhibitors

Publications (2)

Publication Number Publication Date
NO20005548D0 true NO20005548D0 (no) 2000-11-03
NO20005548L NO20005548L (no) 2000-12-04

Family

ID=26324850

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005548A NO20005548L (no) 1998-05-05 2000-11-03 Mykobakterieinhibitorer

Country Status (14)

Country Link
US (1) US6476053B1 (no)
EP (1) EP1075261B1 (no)
JP (1) JP2002518324A (no)
KR (1) KR20010043322A (no)
CN (1) CN1201735C (no)
AT (1) ATE322898T1 (no)
AU (1) AU739140B2 (no)
BR (1) BR9910185A (no)
CA (1) CA2330667A1 (no)
DE (1) DE69930844T2 (no)
IL (1) IL139144A0 (no)
NO (1) NO20005548L (no)
NZ (1) NZ507620A (no)
WO (1) WO1999065483A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2384208T3 (es) 2001-11-01 2012-07-02 Spectrum Pharmaceuticals, Inc. Composiciones medicinales para el tratatamiento intravesical del cáncer de vejiga.
KR20080034944A (ko) * 2005-08-19 2008-04-22 아스트라제네카 아베 결핵 치료용 피라졸론 유도체
GB0520368D0 (en) * 2005-10-06 2005-11-16 Univ Aston Antibacterial pyrrols
JP5653360B2 (ja) * 2008-12-04 2015-01-14 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se 1,3−および1,4−アルキルメチルピロリドンを生成するためのイタコン酸またはイタコン酸誘導体と第1級アミンとの混合物
WO2017112362A1 (en) * 2015-12-23 2017-06-29 Henkel Ag & Co. Kgaa Metal working fluid
CN107033060B (zh) * 2017-05-04 2020-01-14 浙江工业大学 一种n-取代顺丁烯二酰亚胺类化合物及其制备与抗菌应用
US11890364B2 (en) 2017-12-01 2024-02-06 Good T Cells, Inc. Composition for prevention or treatment of hair loss

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883342A (en) * 1973-04-13 1975-05-13 Akzona Inc Plant growth regulators

Also Published As

Publication number Publication date
JP2002518324A (ja) 2002-06-25
BR9910185A (pt) 2001-01-09
EP1075261B1 (en) 2006-04-12
IL139144A0 (en) 2001-11-25
NZ507620A (en) 2003-05-30
CA2330667A1 (en) 1999-12-23
KR20010043322A (ko) 2001-05-25
EP1075261A1 (en) 2001-02-14
CN1308532A (zh) 2001-08-15
WO1999065483A1 (en) 1999-12-23
ATE322898T1 (de) 2006-04-15
AU4304199A (en) 2000-01-05
DE69930844T2 (de) 2006-12-28
DE69930844D1 (de) 2006-05-24
NO20005548L (no) 2000-12-04
AU739140B2 (en) 2001-10-04
US6476053B1 (en) 2002-11-05
CN1201735C (zh) 2005-05-18

Similar Documents

Publication Publication Date Title
DE69905170T2 (de) Thiazolopyrimidinderivate
DE69907977D1 (de) Pyrrolobenzodiazepine
EA199900373A2 (ru) Фармацевтические композиции
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE264863T1 (de) 28-epirapaloge
ES2191152T3 (es) Terapia combinada para el tratamiento de psicosis.
ATE415979T1 (de) Behandlung mit anti-erbb2 antikörpern
IT1285770B1 (it) Composti corticoidei
BR9809185A (pt) Diidropiranos fundidos
CY1107531T1 (el) Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου
SE9904377D0 (sv) Pharmaceutical combinations
ATE386742T1 (de) Imidazonaphthyridine
NO20031860D0 (no) Kahalaolid F
CU23088A3 (es) Compuestos de tetra-hidropiridina.
SE9802937D0 (sv) Novel compounds
SE0301650D0 (sv) Novel compounds
SE9801494D0 (sv) Novel use
IS5951A (is) 5HT1 mótlyf fyrir meðferð gegn þunglyndi
NO20005548L (no) Mykobakterieinhibitorer
TR200200278T2 (tr) Kalsilitik bileşimler
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
BR0316544A (pt) Compostos calcilìticos
TR200103219T2 (tr) Nöropatik ağrının iyileştirilmesinde kullanım için aroil aminoasil piroller
TR200003084T2 (tr) Paroxetine askorbat
DK1133297T3 (da) Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application